EVOLVE Trial - EndoVascular Treatment Of Wide-Neck Aneurysms

Bradley N. Bohnstedt, MD

Primary Investigator

Enrolling By Invitation

18 years - 80 years

All

Phase N/A

35 participants needed

3 Locations

Brief description of study

The purpose of this study is to collect data on the use of the Surpass Evolve Flow Diverter to determine its safety and efficacy.

Detailed description of study

Participants will complete blood clot testing; brain imaging at the time of the procedure and again at 6, 12, and 36-months post-procedure; blood tests; neurological and cranial nerve exams; assessments. Participants will also return to their doctor at 1 month, 6 months, 12 months, 24 months, and 36 months after treatment with the Surpass Evolve Flow Diverter implant.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Wide-Neck Aneurysm
Age: 18 years - 80 years
Gender: All

Individuals between 18 and 80 years of age with a single unruptured intracranial aneurysm with multiple increased risk factors for rupture.

Individuals with certain other serious concurrent medical conditions will not be eligible.

Women who are pregnant will not be eligible.

Updated on 01 Aug 2024. Study ID: 2002543601

Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

This study is accepting only persons who receive care at a certain clinic or doctor or who are part of an invited group. Questions about this study can be directed to the study team listed in the description or contact your doctor to see if you are eligible.

Accepting Referrals by Invitation Only